Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. DELL
3. ROIV
4. LAD
5. TTE
6. ANET
7. NKE
8. BE
9. PANW
10. CL

Go back to Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
(NASDAQ: QTTB) Delayed: 11.99 --0 (-0%)
Previous Close $11.99    52 Week High $ 
Open $11.99    52 Week Low $ 
Day High $11.99    P/E N/A 
Day Low $11.99    EPS $ 
Volume 364